Navigation Links
Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing
Date:5/15/2009

NEW YORK and ATLANTA, May 15 /PRNewswire/ -- Paul Capital Healthcare today announced that New York-based partner, John Leone, will participate in a panel on non-traditional forms of financing at the 2009 BIO International Convention. Designed to familiarize participants with how to evaluate non-dilutive financing options that can meet the needs of companies at diverse stages of development, the panel, "Non-dilutive and Other Non-traditional Forms of Financing," is scheduled for 2:00-3:30 pm ET, Wednesday, May 20th. The panel, presented as part of the Biotechnology Industry Organization International Convention, will be held at the Georgia World Congress Center in Atlanta.

Relevant at a time when IPOs are hard to execute and equity valuations uncertain, this panel will explore various models for obtaining capital for product development other than through equity finance. Mr. Leone will provide an overview and case studies of royalty and structured revenue financing transactions, as well as discuss how these financing strategies are critical for biotechnology companies in the months ahead.

"In the current financial environment, obtaining capital from traditional equity and debt markets is exceedingly difficult for small- and mid-size biotechnology companies," said John Leone, partner at Paul Capital Healthcare. "The total value of biotechnology financing transactions in 2008 was down 50% compared with 2007, and data from the first quarter of 2009 suggest that the environment will remain challenging over the near term. At the same time, increasing development costs coupled with favorable healthcare market dynamics continue to fuel the funding needs of biotechnology companies. Fortunately, there are a variety of alternative financing strategies available to companies across all stages of development, and this panel will provide insight into viable and available methods for accessing capital from investors who are actually doing deals in today's market. Both royalty monetization and revenue interest financing transactions, which are non-dilutive and can be tailored to meet the needs of individual companies, will be discussed."

About Paul Capital Healthcare and Paul Capital Partners

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management. Combined, the Paul Capital Healthcare funds have invested more than $965 million in the pharmaceutical, biotechnology, and medical device sectors. These investments are focused on commercial stage companies and products, and consist of investments in the form of royalties, revenue interests, debt and equity. Additional information on Paul Capital Healthcare can be found at www.paulcapitalhealthcare.com. Paul Capital Partners manages nearly $6.6 billion in equity capital commitments for its three investment platforms, which include Paul Capital Healthcare, Private Equity Secondaries and Top Tier Fund-of-Funds. The firm has offices in New York, San Francisco, Paris, London, Hong Kong, and Sao Paolo.

    Contact Information:
    Paul Capital Healthcare
    John Leone, Partner
    Tel: (646) 264-1144
    Email: jleone@paulcap.com

    Lazar Partners
    Stephanie Seiler
    Tel: (206) 713-0124
    Email: sseiler@lazarpartners.com
    Susan Rood
    Tel: (212) 843-0210
    Email: srood@lazarpartners.com


'/>"/>
SOURCE Paul Capital Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
Breaking Medicine Technology: